Cargando…
The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event
This retrospective multi-center analysis aimed to assess the clinical response and stabilizing effects of palliative radiotherapy (RT) for spinal bone metastases (SBM) in head and neck cancer (HNC), and to establish potential predictive factors for stability and overall survival (OS). Patients inclu...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409283/ https://www.ncbi.nlm.nih.gov/pubmed/32708389 http://dx.doi.org/10.3390/cancers12071950 |
_version_ | 1783568030691753984 |
---|---|
author | Bostel, Tilman Rühle, Alexander Rackwitz, Tilmann Mayer, Arnulf Klodt, Tristan Oebel, Laura Förster, Robert Schlampp, Ingmar Wollschläger, Daniel Rief, Harald Sprave, Tanja Debus, Jürgen Grosu, Anca-Ligia Schmidberger, Heinz Akbaba, Sati Nicolay, Nils Henrik |
author_facet | Bostel, Tilman Rühle, Alexander Rackwitz, Tilmann Mayer, Arnulf Klodt, Tristan Oebel, Laura Förster, Robert Schlampp, Ingmar Wollschläger, Daniel Rief, Harald Sprave, Tanja Debus, Jürgen Grosu, Anca-Ligia Schmidberger, Heinz Akbaba, Sati Nicolay, Nils Henrik |
author_sort | Bostel, Tilman |
collection | PubMed |
description | This retrospective multi-center analysis aimed to assess the clinical response and stabilizing effects of palliative radiotherapy (RT) for spinal bone metastases (SBM) in head and neck cancer (HNC), and to establish potential predictive factors for stability and overall survival (OS). Patients included in this analysis were treated at the University Hospitals of Mainz, Freiburg, and Heidelberg between 2001 and 2019. Clinical information was taken from the medical records. The stability of affected vertebral bodies was assessed according to the validated spine instability neoplastic score (SINS) based on CT-imaging before RT, as well as 3 and 6 months after RT. OS was quantified as the time between the start of palliative RT and death from any cause or last follow-up. Potential predictive factors for stability and OS were analyzed using generalized estimating equations and Cox regression for time-varying covariates to take into account multiple observations per patient. The mean follow-up time of 66 included patients after the first palliative RT was 8.1 months (range 0.3–85.0 months). The majority of patients (70%; n = 46) had squamous cell carcinomas (SCC) originating from the pharynx, larynx and oral cavity, while most of the remaining patients (26%; n = 17) suffered from salivary glands tumors. A total of 95 target volumes including 178 SBM were evaluated that received a total of 81 irradiation series. In patients with more than one metastasis per irradiated region, only the most critical bone metastasis was analyzed according to the SINS system. Prior to RT, pain and neurologic deficits were present in 76% (n = 72) and 22% (n = 21) of irradiated lesions, respectively, and 68% of the irradiated lesions (n = 65) were assessed as unstable or potentially unstable prior to RT. SBM-related pain symptoms and neurologic deficits responded to RT in 63% and 47% of the treated lesions, respectively. Among patients still alive at 3 and 6 months after RT with potentially unstable or unstable SBM, a shift to a better stability class according to the SINS was observed in 20% and 33% of the irradiated SBM, respectively. Pathological fractures of SBM were frequently detected before the start of irradiation (43%; n = 41), but after RT, new fractures or increasing vertebral body sintering within the irradiated region occurred rarely (8%; n = 8). A pathological fracture before RT was negatively associated with stabilization 6 months after RT (OR 0.1, 95% CI 0.02–0.49, p = 0.004), while a Karnofsky performance score (KPS) ≥ 70% was associated positively with a stabilization effect through irradiation (OR 6.09, 95% CI 1.68–22.05, p = 0.006). Mean OS following first palliative RT was 10.7 months, and the KPS (≥70% vs. <70%) was shown to be a strong predictive factor for OS after RT (HR 0.197, 95% CI 0.11–0.35, p < 0.001). There was no significant difference in OS between patients with SCC and non-SCC. Palliative RT in symptomatic SBM of HNC provides sufficient symptom relief in the majority of patients, while only about one third of initially unstable SBM show re-stabilization after RT. Since patients in our multi-center cohort exhibited very limited OS, fractionation schemes should be determined depending on the patients’ performance status. |
format | Online Article Text |
id | pubmed-7409283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74092832020-08-25 The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event Bostel, Tilman Rühle, Alexander Rackwitz, Tilmann Mayer, Arnulf Klodt, Tristan Oebel, Laura Förster, Robert Schlampp, Ingmar Wollschläger, Daniel Rief, Harald Sprave, Tanja Debus, Jürgen Grosu, Anca-Ligia Schmidberger, Heinz Akbaba, Sati Nicolay, Nils Henrik Cancers (Basel) Article This retrospective multi-center analysis aimed to assess the clinical response and stabilizing effects of palliative radiotherapy (RT) for spinal bone metastases (SBM) in head and neck cancer (HNC), and to establish potential predictive factors for stability and overall survival (OS). Patients included in this analysis were treated at the University Hospitals of Mainz, Freiburg, and Heidelberg between 2001 and 2019. Clinical information was taken from the medical records. The stability of affected vertebral bodies was assessed according to the validated spine instability neoplastic score (SINS) based on CT-imaging before RT, as well as 3 and 6 months after RT. OS was quantified as the time between the start of palliative RT and death from any cause or last follow-up. Potential predictive factors for stability and OS were analyzed using generalized estimating equations and Cox regression for time-varying covariates to take into account multiple observations per patient. The mean follow-up time of 66 included patients after the first palliative RT was 8.1 months (range 0.3–85.0 months). The majority of patients (70%; n = 46) had squamous cell carcinomas (SCC) originating from the pharynx, larynx and oral cavity, while most of the remaining patients (26%; n = 17) suffered from salivary glands tumors. A total of 95 target volumes including 178 SBM were evaluated that received a total of 81 irradiation series. In patients with more than one metastasis per irradiated region, only the most critical bone metastasis was analyzed according to the SINS system. Prior to RT, pain and neurologic deficits were present in 76% (n = 72) and 22% (n = 21) of irradiated lesions, respectively, and 68% of the irradiated lesions (n = 65) were assessed as unstable or potentially unstable prior to RT. SBM-related pain symptoms and neurologic deficits responded to RT in 63% and 47% of the treated lesions, respectively. Among patients still alive at 3 and 6 months after RT with potentially unstable or unstable SBM, a shift to a better stability class according to the SINS was observed in 20% and 33% of the irradiated SBM, respectively. Pathological fractures of SBM were frequently detected before the start of irradiation (43%; n = 41), but after RT, new fractures or increasing vertebral body sintering within the irradiated region occurred rarely (8%; n = 8). A pathological fracture before RT was negatively associated with stabilization 6 months after RT (OR 0.1, 95% CI 0.02–0.49, p = 0.004), while a Karnofsky performance score (KPS) ≥ 70% was associated positively with a stabilization effect through irradiation (OR 6.09, 95% CI 1.68–22.05, p = 0.006). Mean OS following first palliative RT was 10.7 months, and the KPS (≥70% vs. <70%) was shown to be a strong predictive factor for OS after RT (HR 0.197, 95% CI 0.11–0.35, p < 0.001). There was no significant difference in OS between patients with SCC and non-SCC. Palliative RT in symptomatic SBM of HNC provides sufficient symptom relief in the majority of patients, while only about one third of initially unstable SBM show re-stabilization after RT. Since patients in our multi-center cohort exhibited very limited OS, fractionation schemes should be determined depending on the patients’ performance status. MDPI 2020-07-18 /pmc/articles/PMC7409283/ /pubmed/32708389 http://dx.doi.org/10.3390/cancers12071950 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bostel, Tilman Rühle, Alexander Rackwitz, Tilmann Mayer, Arnulf Klodt, Tristan Oebel, Laura Förster, Robert Schlampp, Ingmar Wollschläger, Daniel Rief, Harald Sprave, Tanja Debus, Jürgen Grosu, Anca-Ligia Schmidberger, Heinz Akbaba, Sati Nicolay, Nils Henrik The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event |
title | The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event |
title_full | The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event |
title_fullStr | The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event |
title_full_unstemmed | The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event |
title_short | The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event |
title_sort | role of palliative radiotherapy in the treatment of spinal bone metastases from head and neck tumors—a multicenter analysis of a rare event |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409283/ https://www.ncbi.nlm.nih.gov/pubmed/32708389 http://dx.doi.org/10.3390/cancers12071950 |
work_keys_str_mv | AT bosteltilman theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT ruhlealexander theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT rackwitztilmann theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT mayerarnulf theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT klodttristan theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT oebellaura theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT forsterrobert theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT schlamppingmar theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT wollschlagerdaniel theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT riefharald theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT spravetanja theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT debusjurgen theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT grosuancaligia theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT schmidbergerheinz theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT akbabasati theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT nicolaynilshenrik theroleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT bosteltilman roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT ruhlealexander roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT rackwitztilmann roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT mayerarnulf roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT klodttristan roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT oebellaura roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT forsterrobert roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT schlamppingmar roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT wollschlagerdaniel roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT riefharald roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT spravetanja roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT debusjurgen roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT grosuancaligia roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT schmidbergerheinz roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT akbabasati roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent AT nicolaynilshenrik roleofpalliativeradiotherapyinthetreatmentofspinalbonemetastasesfromheadandnecktumorsamulticenteranalysisofarareevent |